MARKET

CDIO

CDIO

Cardio Diagnostics Holdings Inc
NASDAQ
3.650
+0.610
+20.07%
After Hours: 3.648 -0.002 -0.04% 19:44 12/05 EST
OPEN
3.030
PREV CLOSE
3.040
HIGH
3.650
LOW
3.030
VOLUME
36.71K
TURNOVER
--
52 WEEK HIGH
53.10
52 WEEK LOW
2.424
MARKET CAP
6.67M
P/E (TTM)
-0.8970
1D
5D
1M
3M
1Y
5Y
1D
Cardio Diagnostics gets gapfill payment rate for Epi+Gen, Precision CHD tests
TipRanks · 2d ago
CARDIO DIAGNOSTICS HOLDINGS INC - CMS SETS FINAL PAYMENT RATE OF $854 FOR CARDIOVASCULAR TESTS
Reuters · 2d ago
Cardio Diagnostics Receives Final Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)
Barchart · 3d ago
Weekly Report: what happened at CDIO last week (1124-1128)?
Weekly Report · 5d ago
Weekly Report: what happened at CDIO last week (1117-1121)?
Weekly Report · 11/24 09:08
Weekly Report: what happened at CDIO last week (1110-1114)?
Weekly Report · 11/17 09:07
Weekly Report: what happened at CDIO last week (1103-1107)?
Weekly Report · 11/10 09:07
Cardio Diagnostics' PrecisionCHD Test To Detect Hidden Forms Of Heart Disease INOCA And MINOCA, To Be Presented At AHA Sessions
Benzinga · 11/05 13:37
More
About CDIO
Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development, and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.

Webull offers Cardio Diagnostics Holdings Inc stock information, including NASDAQ: CDIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CDIO stock methods without spending real money on the virtual paper trading platform.